Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial

BACKGROUND: Nutraceuticals represent a new therapeutic frontier in the treatment of metabolic syndrom (MetS) and related cardiovascular risk factors. The aim of this study was to evaluate the potential beneficial effects of Armolipid Plus (AP) (berberine 500 mg, red yest rice, monacolin K 3 mg and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Galletti, Ferruccio, Fazio, Valeria, Gentile, Marco, Schillaci, Giuseppe, Pucci, Giacomo, Battista, Francesca, Mercurio, Valentina, Bosso, Giorgio, Bonaduce, Domenico, Brambilla, Nadia, Vitalini, Cristina, D’Amato, Massimo, Giacovelli, Giampaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421674/
https://www.ncbi.nlm.nih.gov/pubmed/30885221
http://dx.doi.org/10.1186/s12944-019-1002-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421674/
https://www.ncbi.nlm.nih.gov/pubmed/30885221
http://dx.doi.org/10.1186/s12944-019-1002-y

Ejemplares similares